(Q53694062)
Statements
A phase II dose-ranging study of the phosphodiesterase inhibitor K-134 in patients with peripheral artery disease and claudication. (English)
1 reference
William R Hiatt
1 reference
Eric P Brass
1 reference
Leslie T Cooper
1 reference
Roger E Morgan
1 reference
25 November 2011
1 reference
55
1 reference
2
1 reference
381-389.e1
1 reference
Identifiers
1 reference